IL17A and endocrine-cerebro-osteodysplasia syndrome: To further understand the differences between PSC and non-PSC ECO, IL-17A treated ECO only (IL-17A treated PSC vs. IL-17A treated non-PSC ECO) were selected, and DEGs were investigated between these 2 cohorts.